Department of Obstetrics and Gynaecology

Pap IVa (Papanicolaou-Karzinomdiagnostik) beim Zervixkarzinomscreening: Wie geht’s weiter? (2021) Stübs F, Gaß P, Beckmann M Journal article Nebenwirkungen oraler Therapien in der gynäkologischen Onkologie (2021) Pöschke P, Beckmann M, Gaß P Journal article The Diagnosis, Treatment, and Aftercare of Cervical Carcinoma. (2021) Beckmann M, Stübs F, Vordermark D, Koch MC, Horn LC, Fehm T Journal article Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2-Advanced Breast Cancer (2021) Fasching P, Delea TE, Lu YS, De Boer R, Hurvitz SA, Moynahan A, Chandiwana D, et al. Journal article Adjuvant radiotherapy and local recurrence in vulvar cancer – a subset analysis of the AGO-CaRE-1 study (2021) Woelber L, Prieske K, Eulenburg Cz, Corradini S, Petersen C, Bommert M, Blankenstein T, et al. Journal article Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer (2021) Schneeweiss A, Michel LL, Möbus V, Tesch H, Klare P, Hahnen E, Denkert C, et al. Journal article Erratum: AGO Recommendations for the Surgical Therapy of the Axilla after Neoadjuvant Chemotherapy: 2021 Update (Geburtshilfe Frauenheilkd (2021) 81:10 (1112-1120) DOI: 10.1055/a-1499-8431) (2021) Friedrich M, Kühn T, Janni W, Müller V, Banys-Paluchowski M, Kolberg-Liedtke C, Jackisch C, et al. Journal article, Erratum Stellenwert der Vakzine gegen humane Papillomaviren in der Prävention von Krebserkrankungen (2021) Schulmeyer C, Knöll A, Iro H, Müller S, Beckmann M Journal article, Review article Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial (2021) Llop-Guevara A, Loibl S, Villacampa G, Vladimirova V, Schneeweiss A, Karn T, Zahm DM, et al. Journal article Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer (2021) Konecny GE, Hendrickson AE, Davidson TM, Winterhoff BJ, Ma S, Mahner S, Sehouli J, et al. Journal article